New ‘discreet’ Viagra Launched ending Embarrassment Of Blue Pill

The makers of Viagra are set to introduce a brand-new ‘discrete’ form of the drug that will change the iconic – and quickly recognisable – little blue pill.

The distinct diamond-shaped tablets could quickly be replaced by a pink, rectangle-shaped ‘wafer’ that liquifies on the tongue, implying it does not need to be taken with water.

About half of guys over 40 suffer erectile dysfunction in the UK and last year there was a record 4.57 million prescriptions for Viagra on the NHS.

The drug first concerned the market in the 1990s after being developed by the American pharmaceutical business Pfizer.

It was first developed in the 1980s as a heart problem medication, however trial individuals observed it had an unusual adverse effects – regular erections.

Now, Pfizer spin-off Viatris, which owns the Viagra name and brand, has made an application for a trademark in the UK for the brand-new kind of the drug, Viagra ODF.

Viatris has already introduced the Viagra ODF in Canada and promoted it as being ‘thin and discreet’ which might be more effective for many customers.

The distinct tablets – which can trigger humiliation for some patients – has actually been reinvented and a brand-new dissolvable type may be readily available to Brits in the next 5 years. Stock image

are not constantly bearable to clients and likewise often the size of tablets may put clients off having them,’ Thorrun Govind, pharmacist and health professional, told The Telegraph.

She added: ‘Some guys may still be finding the idea of having Viagr humiliating, however I would hope that men’s health and conversations about sexual health have moved on considering that Viagra was first created.’

Ms Govind thinks this new design is a ‘positive advance’.

The brand-new dissolvable medication is believed to most likely come to the UK imminently.

Rebecca Anderson-Smith, partner and chartered trade mark lawyer at Mewburn Ellis, told the newspaper that the trademark application is a ‘great sign’ it will be available within the next 5 years.

She described trade mark registrations can be cancelled if they are not used for a constant duration of 5 years or more after registration. As an outcome, it seems Viatris plans to launch the product within the next few years.

However, approving a trademark would not guarantee the ODF might be offered and it would need to be authorized by the Medicines & Healthcare products Regulatory Agency first.

It’s anticipated to cost the same as the tablet variation and to be available in the same dosages.

An overall of 4.57 million prescriptions for sildenafil, more typically understood by the brand name Viagra, and other types of impotency drugs offered under the trademark name Cialis and Levitra, were dispensed by the health service in 2023

This comes after dodgy Viagra was found to be Britain’s greatest counterfeit drug after more than ₤ 6.2 million of fake blue pill were taken by UK regulators in 2023.

More supplies of the erectile dysfunction drug were found than knock-off versions of painkillers like morphine.

Health authorities stated online sellers flouting policies lagged the fake products with the majority of being imported from countries like India without a suitable licence.

Data, from UK regulator The Medicines and Healthcare products Regulatory Agency (MHRA), reveal 2.6 million dosages of sildenafil, the generic name for the medication best referred to as Viagra, were taken last year.

Another half-million doses of tadalafil, another erectile dysfunction drug offered under the brand Cialis worth ₤ 1.2 million were likewise taken.

While all medications bring prospective negative effects drugs from undependable sources might either not work or bring extra ingredients or pollutants like heavy metals or other drugs that could be harmful.